About 1 result found for searched term "1629677-75-3" (0.129 seconds)
Cat.No. | Name | Target |
---|---|---|
M21181 | Zetomipzomib | Proteasome |
KZR-616 | ||
Zetomipzomib (KZR-616) is the first immunoproteasome inhibitor that selectively targets the immunoproteasome subunits LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP7/mLMP7). Zetomipzomib has potential for use in a variety of autoimmune diseases. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.